# Efficacy and Safety of a Retinoid in the Treatment of Severe Chronic Hand Eczema

> **NCT00817063** · PHASE3 · COMPLETED · sponsor: **Stiefel, a GSK Company** · enrollment: 599 (actual)

## Conditions studied

- Eczema

## Interventions

- **DRUG:** alitretinoin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00817063
- **Lead sponsor:** Stiefel, a GSK Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-01-08
- **Primary completion:** 2012-04-26
- **Final completion:** 2012-04-26
- **Target enrollment:** 599 (ACTUAL)
- **Last updated:** 2020-04-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00817063

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00817063, "Efficacy and Safety of a Retinoid in the Treatment of Severe Chronic Hand Eczema". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00817063. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*